About PLX Dividend Returns
Protalix BioTherapeutics, Inc. (PLX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of PLX over the past year?
Protalix BioTherapeutics, Inc. (PLX) delivered a return of 23.61% over the past year. Since PLX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in PLX be worth today?
A $10,000 investment in Protalix BioTherapeutics, Inc. one year ago would be worth $12,361 today, representing a gain of $2,361.
Q3Does PLX pay dividends?
Protalix BioTherapeutics, Inc. (PLX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PLX, the total return equals the price-only return.
Q4Did PLX beat the S&P 500?
Yes, Protalix BioTherapeutics, Inc. (PLX) outperformed the S&P 500 by 8.15 percentage points over the past year. PLX delivered a total return of 23.61%, compared to the S&P 500's 15.45%. This 8.15pp alpha means investors in PLX earned more than a passive S&P 500 index fund.
Q5What is PLX's worst drawdown?
Protalix BioTherapeutics, Inc. (PLX) experienced a maximum drawdown of -56.03% over the past year, declining from its peak on 2025-04-30 to its trough on 2025-06-23. The stock recovered to its prior peak by 2026-02-19. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is PLX's long-term total return over 10, 20, or 30 years?
Protalix BioTherapeutics, Inc. (PLX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -65.4% (-10.1% CAGR) — $10,000 would have grown to $3,462. Over 20 years: -99.2% total return (-21.6% CAGR) — $10,000 → $78. Over 30 years: -99.7% total return (-17.3% CAGR) — $10,000 → $34. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was PLX's best and worst year?
Protalix BioTherapeutics, Inc.'s best calendar year was 2005 with a total return of 2025.0%. Its worst year was 2007 with a total return of -87.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 2112.5 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).